OverviewChartNewsTraderScreen

Goldman Sachs Knock-Out LONN/  DE000GG5GJC8  /

EUWAX
11/14/2024  9:49:00 AM Chg.+0.24 Bid11:56:45 AM Ask11:56:45 AM Underlying Strike price Expiration date Option type
8.20EUR +3.02% 8.42
Bid Size: 10,000		 8.45
Ask Size: 10,000		 LONZA N 477.8858 CHF 12/31/2078 Call
GlobeNewswire 8/26 Simtra BioPharma Solutions Appoints Dr. Lidia Serina as Head of Development Sciences
GlobeNewswire 8/23 Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, G...
GlobeNewswire 8/8 Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/6 Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 6/14 Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire 6/13 Repligen Announces CEO Transition Plan
GlobeNewswire 5/30 Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire 5/15 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire 5/8 Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 Maravai LifeSciences Reports First Quarter 2024 Financial Results
GlobeNewswire 4/4 Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire 4/4 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 2/27 Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 2/15 Galapagos presents at EBMT-EHA annual meeting 2024
GlobeNewswire 1/4 Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire 12/19/2023 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire 12/9/2023 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire 12/7/2023 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire 12/7/2023 Business Update
GlobeNewswire 11/6/2023 Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 11/1/2023 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 10/19/2023 Viralgen welcomes back Andy Holt as CCO
GlobeNewswire 10/16/2023 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 10/2/2023 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 9/20/2023 Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023